The Cigna Group (NYSE:CI) PT Raised to $422.00 at Jefferies Financial Group

The Cigna Group (NYSE:CI) had its price target raised by research analysts at Jefferies Financial Group from $402.00 to $422.00 in a research report issued to clients and investors on Tuesday, Benzinga reports. The brokerage presently has a “buy” rating on the health services provider’s stock. Jefferies Financial Group’s target price suggests a potential upside of 17.37% from the company’s current price.

Several other research firms have also issued reports on CI. Baird R W upgraded The Cigna Group to a “strong-buy” rating in a research report on Thursday, May 30th. StockNews.com upgraded shares of The Cigna Group from a “buy” rating to a “strong-buy” rating in a report on Friday, August 2nd. Stephens reiterated an “overweight” rating and issued a $410.00 target price on shares of The Cigna Group in a report on Friday, August 2nd. Robert W. Baird began coverage on shares of The Cigna Group in a research report on Thursday, May 30th. They set an “outperform” rating and a $388.00 price target on the stock. Finally, Piper Sandler assumed coverage on shares of The Cigna Group in a research report on Wednesday, June 26th. They issued an “overweight” rating and a $400.00 price objective for the company. One equities research analyst has rated the stock with a hold rating, thirteen have assigned a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Buy” and an average target price of $392.79.

The Cigna Group Trading Down 2.0 %

CI stock traded down $7.31 during midday trading on Tuesday, reaching $359.54. The company’s stock had a trading volume of 169,209 shares, compared to its average volume of 1,510,956. The business’s 50-day simple moving average is $345.05 and its 200-day simple moving average is $344.51. The stock has a market cap of $102.14 billion, a PE ratio of 29.80, a price-to-earnings-growth ratio of 1.09 and a beta of 0.50. The Cigna Group has a 52 week low of $253.95 and a 52 week high of $370.83. The company has a quick ratio of 0.71, a current ratio of 0.71 and a debt-to-equity ratio of 0.73.

The Cigna Group (NYSE:CI) last posted its quarterly earnings results on Thursday, August 1st. The health services provider reported $6.72 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.42 by $0.30. The business had revenue of $60.52 billion for the quarter, compared to analyst estimates of $58.30 billion. The Cigna Group had a return on equity of 17.83% and a net margin of 1.70%. The firm’s revenue was up 24.6% on a year-over-year basis. During the same period last year, the company earned $6.13 EPS. As a group, sell-side analysts expect that The Cigna Group will post 28.48 EPS for the current year.

Insider Buying and Selling at The Cigna Group

In other news, Director William J. Delaney III sold 2,691 shares of the firm’s stock in a transaction that occurred on Monday, August 19th. The shares were sold at an average price of $342.68, for a total transaction of $922,151.88. Following the completion of the transaction, the director now directly owns 17,539 shares of the company’s stock, valued at approximately $6,010,264.52. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. In related news, insider Brian C. Evanko sold 4,795 shares of The Cigna Group stock in a transaction dated Monday, June 24th. The stock was sold at an average price of $345.01, for a total value of $1,654,322.95. Following the sale, the insider now owns 39,923 shares of the company’s stock, valued at $13,773,834.23. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director William J. Delaney III sold 2,691 shares of the company’s stock in a transaction dated Monday, August 19th. The stock was sold at an average price of $342.68, for a total value of $922,151.88. Following the sale, the director now owns 17,539 shares in the company, valued at approximately $6,010,264.52. The disclosure for this sale can be found here. Company insiders own 0.60% of the company’s stock.

Institutional Investors Weigh In On The Cigna Group

Institutional investors and hedge funds have recently made changes to their positions in the stock. Sanctuary Advisors LLC acquired a new position in The Cigna Group during the second quarter worth $13,895,000. Brown Financial Advisors acquired a new position in shares of The Cigna Group during the 2nd quarter worth about $1,700,000. Kestra Investment Management LLC acquired a new position in shares of The Cigna Group during the 2nd quarter worth about $439,000. Clearbridge Investments LLC raised its holdings in shares of The Cigna Group by 154.9% in the 2nd quarter. Clearbridge Investments LLC now owns 3,525 shares of the health services provider’s stock valued at $1,165,000 after purchasing an additional 2,142 shares during the period. Finally, KPP Advisory Services LLC lifted its stake in The Cigna Group by 5.0% in the 2nd quarter. KPP Advisory Services LLC now owns 1,176 shares of the health services provider’s stock valued at $389,000 after purchasing an additional 56 shares during the last quarter. Institutional investors own 86.99% of the company’s stock.

The Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.